Fact CheckerSign in

NCT01483664Active, not recruiting

Communication Skills Intervention to Promote Transition Into Survivorship

Source: ClinicalTrials.gov · Last updated 20 Jan 2026

Brief summary (registry, in English)

The purpose of this study is to improve the communication skills of physicians who transition lymphoma cancer patients from the end of treatment to survivorship.

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
314 (actual)
First submitted
29 Nov 2011
Start date
Nov 2011
Primary completion date
Nov 2026
Lead sponsor
Memorial Sloan Kettering Cancer Center
NCT number
NCT01483664

What you commit to

  • Study type: Observational
  • Participants enrolled: 314
  • From Nov 2011 to the primary completion date, Nov 2026
  • 9 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • show evidence of cognitive impairment severe enough to preclude giving permission to the study staff, or completing the survey instruments of the study.

Other

  • Physicians:
  • who do not have adequate patients in their clinical practice to meet the 8 patient enrollment requirement for patients with either DLBCL or HD as per self report
    • Patients of Physicians:
  • as per physician judgment, patient's prognosis and/or co-morbidities make them inappropriate for participation in a survivorship study.
    • For Part 2 ONLY (longitudinal phase):
  • those who consented to part 1, consult recording, of the study.

Who the study is looking for

  • Physicians:
  • who treat patients with DLBCL and HD as per self report
    • Patients of Physicians:
  • have a new diagnosis of Hodgkin's or Diffuse Large B-cell Lymphoma as per pathology report or physician assessment in medical record and/or clinical judgment of the treating physician treated with curative intent.
    • For part 1 - have scans indicating remission and completing planned chemotherapy and/or radiation therapy. The treating physician will determine that clinical remission has been achieved based on their best judgment.
    • For part 2 (longitudinal phase): - have new scans indicating remission and completing planned chemotherapy and/or radiation therapy. The treating physician will determine that clinical remission has been achieved based on their best judgment.
  • be at least 18 years old
  • speak English well enough, in the judgment of the consenting professional, to be able to understand all aspects of the study, provide informed consent, and be able to complete all study measures.

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (9)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Memorial Sloan Kettering at Basking Ridge
Coordinator of this site? Confirm its status
Basking RidgeUnited StatesUnknown status
Maimonides Medical Center
Coordinator of this site? Confirm its status
BrooklynUnited StatesUnknown status
Memorial Sloan Kettering Cancer Center at Commack
Coordinator of this site? Confirm its status
CommackUnited StatesUnknown status
MD Anderson Cancer Center
Coordinator of this site? Confirm its status
HoustonUnited StatesUnknown status
Memorial Sloan-Kettering Cancer Center
Coordinator of this site? Confirm its status
New YorkUnited StatesUnknown status
Memorial Sloan Kettering Cancer Center at Mercy
Coordinator of this site? Confirm its status
Rockville CentreUnited StatesUnknown status
Memorial Sloan Kettering Cancer Center at Phelps
Coordinator of this site? Confirm its status
Sleepy HollowUnited StatesUnknown status
Tampa General Hospital
Coordinator of this site? Confirm its status
TampaUnited StatesUnknown status
Moffitt Cancer Center
Coordinator of this site? Confirm its status
TampaUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.